Enzymology of Cancer Cells

New England Journal of Medicine

Volumn 296, Issue 9, 1977, Pages 486-493

  Weber, George ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ENZYME; NUCLEIC ACID; PYRIMIDINE;

CANCER CELL; CELL METABOLISM; DIAGNOSIS; HISTOLOGY; IN VITRO STUDY; METHODOLOGY; REVIEW;

ANIMAL; ANTINEOPLASTIC AGENTS; CELL TRANSFORMATION, NEOPLASTIC; DNA, NEOPLASM; HUMAN; MODELS, BIOLOGICAL; NEOPLASMS; NEOPLASMS, EXPERIMENTAL; PYRIMIDINES; RATS; SUPPORT, U.S. GOV'T, P.H.S.; THYMIDINE; TRANSLATION, GENETIC;

EID: 0017364109     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197703032960905     Document Type: Review

References (59)

1. Frei E III; Combination cancer therapy: presidential address. Cancer Res 32: 2593–2607, 1972
2. Zubrod CG: Chemical control of cancer, Proc Natl Acad Sci USA 69: 1042–1047, 1972
3. Weinstein L: Antimicrobial agents: general considerations, The Pharmacological Basis of Therapeutics. Fifth edition. Edited by LS Goodman, A Gilman. New York, Macmillan, 1975, p 1104
4. Holland JF, Frei E III: Cancer Medicine. Philadelphia, Lea and Febiger, 1973
5. Calabresi P, Parks RE Jr: Chemotherapy of neoplastic diseases. The Pharmacological Basis of Therapeutics. Fifth edition. Edited by LS Goodman, A Gilman. New York, Macmillan, 1975, pp 1248–1307
6. Weber G, Ferdinandus JA, Queener SF, et al: Metabolic imbalance in carbohydrate, pyrimidine and ornithine utilization. Adv Enzyme Regul 10: 39–62, 1972
7. Weber G: Behavior of liver enzymes during hepatocarcinogenesis, Adv Cancer Res 6: 403–494, 1961
8. Weber: Behavior and regulation of enzyme systems in normal liver and in hepatomas of different growth rates. Adv Enzyme Regul 1: 321–340, 1963
9. Weber: Carbohydrate metabolism in cancer cells and the molecular correlation concept. Naturwissenschaften 55: 418–429, 1968
10. Idem: The molecular correlation concept: recent advances and implications, The Molecular Biology of Cancer. Edited by H Busch. New York, Academic Press, 1974, pp 487–521
11. Ordered and specific pattern of gene expression in neoplasia. Adv Enzyme Regul 11: 79–102, 1973
12. Weber G, Trevisani A, Heinrich PC: Operation of pleiotropic control in hormonal regulation and in neoplasia. Adv Enzyme Regul 12: 11–41, 1974
13. Rieger R, Michaelis A, Green MM: A Glossary of Genetics and Cytogenetics. New York, Springer-Verlag, 1968, p 346
14. Burnet FM: Immunological Surveillance. New York, Pergamon Press, 1970, p 127
15. Morris HP: Studies on the development, biochemistry and biology of experimental hcpatomas. Adv Cancer Res 9: 227–302, 1965
16. Morris HP, Wagner BP: Induction and transplantation of rat hepatomas with different growth rate (including “minimal deviation” hepatomas). Methods in Cancer Research, Vol 4. Edited by H Busch. New York, Academic Press, 1968, pp 125–152
17. Morris HP, Meranze DR: Induction and some characteristics of “minimal deviation” and other transplantable rat hepatomas. Recent Results Cancer Res 44: 103–114, 1974
18. Weber G, Singhal RL, Srivastava SK: Action of glucocorlicoid as inducer and insulin as suppressor of biosynthesis of hepatic gluconeogenic enzymes. Adv Enzyme Regul 3: 43–75, 1965
19. Weber G: Role of key enzymes in metabolic regulation, Mechanism of Action and Regulation of Enzymes. Vol 32. Edited by T Keleti. New York, North Holland-American Elsevier, 1975, pp 237–251
20. Dunaway G A Jr, Morris IIP, Weber G: Increased phosphofruclokinase concentration in hepatoma 3924-A: enzymic and immunological evidence. Life Sci 11 (2):909–918, 1972
21. Selmeci LE, Weber G: Increased glucose 6-phosphate dehydrogenase concentration in hepatoma 3924-A: enzymic and immunological evidence. FEBS Lett 61: 63–67, 1976
22. Weber G, Prajda N, Williams JC: Biochemical strategy of the cancer cell: malignant transformation-linked enzymatic imbalance. Adv Enzyme Regul 13: 3–25, 1975
23. Klein G, Bregula U, Wiener F, et al: The analysis of malignancy by cell fusion. I. Hybrids between tumour cells and L cell derivatives. J Cell Sci 8: 659–691, 1971
24. Ferdinandus JA, Morris HP, Weber G: Behavior of opposing pathways of thymidine utilization in differentiating, regenerating and neoplastic liver. Cancer Res 31: 550–556, 1971
25. Looney WB, Mayo AA, Allen PM, et al: A mathematical evaluation of tumour growth curves in rapid, intermediate and slow growing rat hepatoma. Br J Cancer 27: 341–344, 1973
26. Lewis AE: Biostatistics. New York, Reinhold, 1966
27. Morris HP, Wagner BP, Meranze DR: Transplantable adenocarcinomas of the rat kidney possessing different growth rates. Cancer Res 30: 1362–1369, 1970
28. Lea MA, Morris HP, Weber G: DNA metabolism in liver and kidney tumors of different growth rates. Cancer Res 28: 71–74, 1968
29. Williamson DH, Krebs HA, Stubbs M, et al: Metabolism of renal tumors in situ and during ischemia. Cancer Res 30: 2049–2054, 1970
30. Knox WE: Enzyme Patterns in Fetal, Adult and Neoplastic Rat Tissues. Basel, S Karger, 1972
31. Knox WE, Horowitz ML, Friedell GH: The proportionality of glutaminase content to growth rate and morphology of rat neoplasms. Cancer Res 29: 669–680, 1969
32. Knox WE, Linder M, Friedell GH: A series of transplantable rat mammary tumors with graded differentiation, growth rate and glutaminase content. Cancer Res 30: 283–287, 1970
33. Greenstein JP: Biochemistry of Cancer. Second edition. New York, Academic Press, 1954
34. Bergel F: Chemistry of Enzymes in Cancer. Springfield, Illinois, CC Thomas, 1961
35. Weber G: Biochemical strategy of gene expression, Search and Discovery: Symposium dedicated to Dr Albert Szent-Gyorgyi. Edited by B Kaminer. New York, Academic Press, 1977
36. Idem: Biochemical Strategy of the Cancer Cell. New York, Pergamon Press (in press).
37. Weber G, Queener SF, Ferdinandus JA: Control of gene expression in carbohydate, pyrimidine and DNA metabolism. Adv Enzyme Regul 9: 63–95, 1971
38. Sweeney MF, Hoffman DH, Poore GA: Enzymes in pyrimidine biosynthesis in Morris hepatomas. Proc Am Assoc Cancer Res 8: 66, 1967
39. Sweeney MJ, Hoffman DH: Dihydroorotate dehydrogenase in liver and Morris hepatomas. Cancer Res 33: 394–396, 1973
40. Hoffman DH, Sweeney MJ: Orotate phosphoribosyl transferase and orotidylic acid decarboxylase activities in liver and Morris hepatomas. Cancer Res 33: 1109–1112, 1973
41. Sweeney MJ, Hoffman DH, Poore GA: Enzymes in pyrimidine biosynthesis. Adv Enzyme Regul 9: 51–61, 1971
42. Sweeney MJ, Parton JW, Hoffman DH: Biosynthesis of uridine-5′monophosphate in rat liver and Morris hepatomas. Adv Enzyme Regul 12: 385–396, 1974
43. Mayfield E Jr, Lyman K, Bresnick E: Incorporation of bicarbonate-l4C into pyrimidines and into ribonucleic acid of the Novikoff asciles tumor cell. Cancer Res 27: 476–481, 1967
44. Ono T, Blair DGR, Potter VR, et al: The comparative enzymology and cell origin of rat hepatomas. IV. Pyrimidine metabolism in minimaldeviation tumors. Cancer Res 23: 240–249, 1963
45. Jones ME: Regulation of pyrimidine and arginine biosynthesis in mammals. Adv Enzyme Regul 9: 19–49, 1971
46. Mori M. Ishida H, Tatibana M: Aggregation states and catalytic properties of the multicnzyme complex catalyzing the initial steps of pyrimidine biosynthesis in rat liver. Biochemistry 14: 2622–2673, 1975
47. Sneider TW, Potter VR, Morris HP: Enzymes of thymidine triphosphate synthesis in selected Morris hepatomas. Cancer Res 29: 40–54, 1969
48. Ove P, Laszlo J, Jenkins; MD, et al: Increased DNA polymerase activity in a series of rat hepatomas. Cancer Res 29: 1557–1561, 1969
49. Baril EF, Jenkins MD, Brown OE, et al: DNA polymerase I and II in rat liver and Morris hepatomas. Cancer Res 33: 1187–1193, 1973
50. Malcy F, Maley GF: Nucleotide interconversions. IV. Activities of deoxycytidylate deaminase and thymidylate synthetase in normal rat liver and hepatomas. Cancer Res 21: 1421–1426, 1961
51. Elford HL, Freese M, Passamani E, et al: Ribonucleotide reductase and cell proliferation. I. Variations of ribonucleotide reductase activity with tumor growth rate in a series of rat hepatomas. J Biol Chcm 245: 5228–5233, 1970
52. Elford HL: Functional regulation of mammalian ribonucleotide reductase. Adv Enzyme Regul 10: 19–38, 1972
53. Baliga BS, Borek E: Metabolism of thymine in tumor tissue: the origins of β-aminoisobutyric acid. Adv Enzyme Regul 13: 27–36, 1975
54. Queener SF, Morris HP, Weber G: Dihydrouracil dehydrogenase activity in normal, differentiating, and regenerating liver and in hepatomas. Cancer Res 31: 1004–1009, 1971
55. Sneider TW, Potter VR: Deoxycytidylate deaminase and related enzymes of thymidine triphosphate metabolism in hepatomas and precancerous rat liver. Adv Enzyme Regul 7: 375–394, 1969
56. Weber G, Prajda N, Jackson RC: Key enzymes of IMP metabolism: transformation- and proliferation-linked alterations in gene expression. Adv Enzyme Regul 14: 3–24, 1976
57. Williams JC, Weber G, Morris HP: Increased UDP kinase activity in rat and human hepatomas. Nature 253: 567–569, 1975
58. Ensminger W, Frei E III, Pitman S, et al: Prevention of methotrexate toxicity by thymidine in man. Proc Am Assoc Cancer Res 17: 282, 1976
59. Jackson RC, Weber G: Enzyme pattern-directed chemotherapy: the effects of combinations of methotrexate, 5-fluorodeoxyuridine and thymidine on rat hepatoma cells in vitro. Biochem Pharmacol 25: 2613–2618, 1976